Booth Andrew — SEC Form 4 filings

SEC reporting owner CIK 1834411. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-01-16 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AbCellera Biologics Inc. (ABCL)Chief Financial Officer62 legs · 79,800 sh · $529,5965

Form 4 filings — Booth Andrew

FiledFormIssuerReported transactionsSource
2026-08-144AbCellera Biologics Inc. (ABCL)Purchase (P): 37,200 @ $10.32EDGAR
2026-06-034AbCellera Biologics Inc. (ABCL)Option exercise (M): 250,000 @ $0.19 · Option exercise (M): 250,000 (derivative) @ $0EDGAR
2026-02-274AbCellera Biologics Inc. (ABCL)Purchase (P): 42,600 @ $3.42EDGAR
2026-01-054AbCellera Biologics Inc. (ABCL)Grant/award (A): 808,898 (derivative) @ $0EDGAR
2025-01-034AbCellera Biologics Inc. (ABCL)Grant/award (A): 1,352,054 (derivative) @ $0EDGAR
2024-01-164AbCellera Biologics Inc. (ABCL)Grant/award (A): 770,416 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834411 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →